(Q38129775)

29 August 2017

Multiple sclerosis: Prospects and promise (English)

1 reference

29 August 2017

0 references

3

Jorge R Oksenberg

1 reference

29 August 2017

1

Stephen L Hauser

1 reference

29 August 2017

2

Jonah R Chan

1 reference

29 August 2017

1 September 2013

1 reference

29 August 2017

1 reference

29 August 2017

74

1 reference

29 August 2017

3

1 reference

29 August 2017

317-327

1 reference

The changing demographic pattern of multiple sclerosis epidemiology

29 August 2017

1 reference

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

21 January 2018

1 reference

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study

21 January 2018

1 reference

Management of secondary progressive multiple sclerosis: prophylactic treatment-past, present, and future aspects

21 January 2018

1 reference

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

21 January 2018

1 reference

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

21 January 2018

1 reference

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned

21 January 2018

1 reference

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

21 January 2018

1 reference

Current and emerging therapies in multiple sclerosis: a systematic review

21 January 2018

1 reference

Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data

21 January 2018

1 reference

Freedom from disease activity in multiple sclerosis

21 January 2018

1 reference

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

21 January 2018

1 reference

Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis

21 January 2018

1 reference

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

21 January 2018

1 reference

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

21 January 2018

1 reference

No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.

21 January 2018

1 reference

Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases

21 January 2018

1 reference

Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis

21 January 2018

1 reference

T cells become licensed in the lung to enter the central nervous system.

21 January 2018

1 reference

Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1

21 January 2018

1 reference

Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells

21 January 2018

1 reference

Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation

21 January 2018

1 reference

Potassium channel KIR4.1 as an immune target in multiple sclerosis

21 January 2018

1 reference

The innate immune system in demyelinating disease

21 January 2018

1 reference

Th17 cells induce Th1-polarizing monocyte-derived dendritic cells

21 January 2018

1 reference

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

21 January 2018

1 reference

Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Aggregation of multiple sclerosis genetic risk variants in multiple and single case families

21 January 2018

1 reference

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

21 January 2018

1 reference

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis

21 January 2018

1 reference

Immunopathology of secondary-progressive multiple sclerosis.

21 January 2018

1 reference

Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.

21 January 2018

1 reference

Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors

21 January 2018

1 reference

Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors

21 January 2018

1 reference

Mitochondrial defects in acute multiple sclerosis lesions

21 January 2018

1 reference

The molecular basis of neurodegeneration in multiple sclerosis

21 January 2018

1 reference

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.

21 January 2018

1 reference

Myelination and support of axonal integrity by glia

21 January 2018

1 reference

Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis.

21 January 2018

1 reference

Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease.

21 January 2018

1 reference

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

21 January 2018

1 reference

Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter

21 January 2018

1 reference

B cells in multiple sclerosis: connecting the dots.

21 January 2018

1 reference

Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

21 January 2018

1 reference

B cell exchange across the blood-brain barrier in multiple sclerosis

21 January 2018

1 reference

Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility

21 January 2018

1 reference

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

21 January 2018

1 reference

Risk in complex genetics: "all models are wrong but some are useful".

21 January 2018

1 reference

Integrating the tools for an individualized prognosis in multiple sclerosis

21 January 2018

1 reference

Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity

21 January 2018

1 reference

A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells

21 January 2018

1 reference

LINGO-1 negatively regulates myelination by oligodendrocytes

21 January 2018

1 reference

Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule

21 January 2018

1 reference

Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination

21 January 2018

1 reference

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

21 January 2018

1 reference

Notch receptor activation inhibits oligodendrocyte differentiation.

21 January 2018

1 reference

Notch1 control of oligodendrocyte differentiation in the spinal cord

21 January 2018

1 reference

Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system

21 January 2018

1 reference

Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination.

21 January 2018

1 reference

Retinoid X receptor gamma signaling accelerates CNS remyelination

21 January 2018

1 reference

The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation

21 January 2018

1 reference

A culture system to study oligodendrocyte myelination processes using engineered nanofibers.

21 January 2018

1 reference

Oligodendroglia metabolically support axons and contribute to neurodegeneration.

21 January 2018

1 reference

Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication

21 January 2018

1 reference

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.24009

1 reference

29 August 2017

1 reference

PubMed ID

23955638